These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32952449)

  • 1. Shortcut Model for Describing Isothermal Batch Preferential Crystallization of Conglomerates and Estimating the Productivity.
    Carneiro T; Bhandari S; Temmel E; Lorenz H; Seidel-Morgenstern A
    Cryst Growth Des; 2019 Sep; 19(9):5189-5203. PubMed ID: 32952449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortcut Model for Batch Preferential Crystallization Coupled with Racemization for Conglomerate-Forming Chiral Systems.
    Bhandari S; Carneiro T; Lorenz H; Seidel-Morgenstern A
    Cryst Growth Des; 2022 Jul; 22(7):4094-4104. PubMed ID: 35818384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of Coupled Preferential Crystallizers for the Efficient Resolution of Conglomerate-Forming Enantiomers.
    Majumder A; Nagy ZK
    Pharmaceutics; 2017 Dec; 9(4):. PubMed ID: 29206148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development.
    Temmel E; Eicke MJ; Cascella F; Seidel-Morgenstern A; Lorenz H
    Cryst Growth Des; 2019 Jun; 19(6):3148-3157. PubMed ID: 32952448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
    Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
    Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems.
    Polenske D; Lorenz H; Seidel-Morgenstern A
    Chirality; 2009 Aug; 21(8):728-37. PubMed ID: 18989897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of ultrasound to chiral crystallization, resolution and deracemization.
    Xiouras C; Fytopoulos A; Jordens J; Boudouvis AG; Van Gerven T; Stefanidis GD
    Ultrason Sonochem; 2018 May; 43():184-192. PubMed ID: 29555274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
    Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
    J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioseparation by crystallization using magnetic substrates.
    Tassinari F; Steidel J; Paltiel S; Fontanesi C; Lahav M; Paltiel Y; Naaman R
    Chem Sci; 2019 May; 10(20):5246-5250. PubMed ID: 31191879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomer-selective magnetization of conglomerates for quantitative chiral separation.
    Ye X; Cui J; Li B; Li N; Wang R; Yan Z; Tan J; Zhang J; Wan X
    Nat Commun; 2019 Apr; 10(1):1964. PubMed ID: 31036813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Reporting Inhibitors: A Single Crystallization Process To Obtain Two Optically Pure Enantiomers.
    Ye X; Cui J; Li B; Li N; Zhang J; Wan X
    Angew Chem Int Ed Engl; 2018 Jul; 57(27):8120-8124. PubMed ID: 29790235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical-Chemical Properties of the Chiral Fungicide Fenamidone and Strategies for Enantioselective Crystallization.
    Kort AK; Lorenz H; Seidel-Morgenstern A
    Chirality; 2016 Jun; 28(6):514-20. PubMed ID: 27225331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
    Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
    J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparative resolution of etodolac enantiomers by preferential crystallization method.
    Dung PT; Trung TQ; Kim KH
    Arch Pharm Res; 2009 Oct; 32(10):1425-31. PubMed ID: 19898806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online monitoring of preferential crystallization of enantiomers.
    Alvarez Rodrigo A; Lorenz H; Seidel-Morgenstern A
    Chirality; 2004 Oct; 16(8):499-508. PubMed ID: 15290684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
    Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
    Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for conglomerate in set of [7]helquat salts: multigram resolution of helicene-viologen hybrid by preferential crystallization.
    Vávra J; Severa L; Císařová I; Klepetářová B; Šaman D; Koval D; Kašička V; Teplý F
    J Org Chem; 2013 Feb; 78(4):1329-42. PubMed ID: 22957746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of preferential crystallization to resolve racemic compounds in a hybrid process.
    Lorenz H; Polenske D; Seidel-Morgenstern A
    Chirality; 2006 Nov; 18(10):828-40. PubMed ID: 16917833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Chiral Resolution of Two Racemic Compounds by Preferential Cocrystallization*.
    Zhou F; Shemchuk O; Charpentier MD; Matheys C; Collard L; Ter Horst JH; Leyssens T
    Angew Chem Int Ed Engl; 2021 Sep; 60(37):20264-20268. PubMed ID: 34233036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.